BioMarin Pharmaceuticals
BMRN
BMRN
447 hedge funds and large institutions have $17.2B invested in BioMarin Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 138 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more capital invested
Capital invested by funds: $14.6B → $17.2B (+$2.59B)
4% more funds holding
Funds holding: 429 → 447 (+18)
1.1% more ownership
Funds ownership: 102.41% → 103.51% (+1.1%)
Holders
447
Holding in Top 10
12
Calls
$180M
Puts
$115M
Top Buyers
| 1 | +$212M | |
| 2 | +$150M | |
| 3 | +$149M | |
| 4 |
SIG
Senator Investment Group
New York
|
+$94.2M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$48.4M |
Top Sellers
| 1 | -$192M | |
| 2 | -$102M | |
| 3 | -$83.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$83.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$58.5M |